8KAK image
Deposition Date 2023-08-03
Release Date 2024-06-05
Last Version Date 2025-04-23
Entry Detail
PDB ID:
8KAK
Title:
Crystal structure of SpyCas9 in complex with sgRNA and 18nt target DNA
Biological Source:
Source Organism:
Method Details:
Experimental Method:
Resolution:
3.60 Å
R-Value Free:
0.29
R-Value Work:
0.26
R-Value Observed:
0.26
Space Group:
P 1
Macromolecular Entities
Polymer Type:polyribonucleotide
Molecule:RNA (98-MER)
Chain IDs:A, E
Chain Length:98
Number of Molecules:2
Biological Source:Streptococcus pyogenes serotype M1
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:CRISPR-associated endonuclease Cas9/Csn1
Gene (Uniprot):cas9
Chain IDs:B, F
Chain Length:1368
Number of Molecules:2
Biological Source:Streptococcus pyogenes serotype M1
Polymer Type:polydeoxyribonucleotide
Molecule:DNA (26-MER)
Chain IDs:C, G
Chain Length:26
Number of Molecules:2
Biological Source:Streptococcus pyogenes serotype M1
Polymer Type:polydeoxyribonucleotide
Molecule:DNA (5'-D(*TP*TP*TP*AP*GP*GP*TP*AP*TP*TP*G)-3')
Chain IDs:D, H
Chain Length:11
Number of Molecules:2
Biological Source:Streptococcus pyogenes serotype M1
Ligand Molecules
Primary Citation
Trans-nuclease activity of Cas9 activated by DNA or RNA target binding.
Nat.Biotechnol. 43 558 568 (2025)
PMID: 38811761 DOI: 10.1038/s41587-024-02255-7

Abstact

Type V and type VI CRISPR-Cas systems have been shown to cleave nonspecific single-stranded DNA (ssDNA) or single-stranded RNA (ssRNA) in trans, but this has not been observed in type II CRISPR-Cas systems using single guide RNA. We show here that the type II CRISPR-Cas9 systems directed by CRISPR RNA and trans-activating CRISPR RNA dual RNAs show RuvC domain-dependent trans-cleavage activity for both ssDNA and ssRNA substrates. Cas9 possesses sequence preferences for trans-cleavage substrates, preferring to cleave T- or C-rich ssDNA substrates. We find that the trans-cleavage activity of Cas9 can be activated by target ssDNA, double-stranded DNA and ssRNA. The crystal structure of Cas9 in complex with guide RNA and target RNA provides a structural basis for the binding of target RNA to activate Cas9. Based on the trans-cleavage activity of Cas9 and nucleic acid amplification technology, we develop the nucleic acid detection platforms DNA-activated Cas9 detection and RNA-activated Cas9 detection, which are capable of detecting DNA and RNA samples with high sensitivity and specificity.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
Feedback Form
Name
Email
Institute
Feedback